Stay updated on FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate the study is no longer enrolling participants. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header formatting, along with a revision bump to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-15T19:10:02.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page footer revision has been updated from v3.5.4 to v3.5.5. This indicates a new version of the page was published on ClinicalTrials.gov.
    Difference
    0.0%
    Check dated 2026-06-08T14:55:21.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added, replacing Revision: v3.5.3, indicating a minor update to the page's version tag. This does not change the study content or how information is displayed.
    Difference
    0.0%
    Check dated 2026-05-18T03:43:34.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page’s site revision/version indicator has been updated from **v3.5.0** to **v3.5.3**, reflecting a software release rather than a change to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-26T15:26:12.000Z thumbnail image
  6. Check
    86 days ago
    Change Detected
    Summary
    Added Cutaneous neuroendocrine carcinoma and Small cell lung carcinoma to the study's conditions list.
    Difference
    0.1%
    Check dated 2026-03-29T00:41:14.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    Hepatocellular carcinoma was added to the study's conditions list. The page revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T19:02:46.000Z thumbnail image

Stay in the know with updates to FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.